Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for abrdn Healthcare Investors (HQH : NYSE)
 
 • Company Description   
Tekla Healthcare Investors is a diversified closed-end management investment company. It primarily invests in the healthcare industry (including biotechnology, medical devices, and pharmaceuticals). The Fund's objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. Tekla Healthcare Investors, formerly known as H&Q Healthcare Investors, is based in Boston, Massachusetts.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $15.20 Daily Weekly Monthly
20 Day Moving Average: 172,027 shares
Shares Outstanding: 53.86 (millions)
Market Capitalization: $818.71 (millions)
Beta: 0.79
52 Week High: $19.30
52 Week Low: $13.77
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.15% -3.20%
12 Week -15.32% -8.52%
Year To Date -5.30% -1.59%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2 LIBERTY SQUARE 9TH FLOOR
-
BOSTON,MA 02109
USA
ph: 617-772-8500
fax: 617-772-8577
info@teklacap.com http://www.teklacap.com
 
 • General Corporate Information   
Officers
Daniel R. Omstead - President
Laura Woodward - Treasurer and Secretary
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: FIN-INVEST FUND
Sector: Finance
CUSIP: 87911J103
SIC: 6726
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 53.86
Most Recent Split Date: (:1)
Beta: 0.79
Market Capitalization: $818.71 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 15.59%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $2.37
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/21/2025 - $0.57
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/25 - -
12/31/24 - -
09/30/24 - -
ROA
03/31/25 - -
12/31/24 - -
09/30/24 - -
Current Ratio
03/31/25 - -
12/31/24 - -
09/30/24 - -
Quick Ratio
03/31/25 - -
12/31/24 - -
09/30/24 - -
Operating Margin
03/31/25 - -
12/31/24 - -
09/30/24 - -
Net Margin
03/31/25 - -
12/31/24 - -
09/30/24 - -
Pre-Tax Margin
03/31/25 - -
12/31/24 - -
09/30/24 - -
Book Value
03/31/25 - -
12/31/24 - -
09/30/24 - -
Inventory Turnover
03/31/25 - -
12/31/24 - -
09/30/24 - -
Debt-to-Equity
03/31/25 - -
12/31/24 - -
09/30/24 - -
Debt-to-Capital
03/31/25 - -
12/31/24 - -
09/30/24 - -
 

Powered by Zacks Investment Research ©